Department of Error

No authors listed

Published Erratum

No authors listed. Lancet. 2024.

. 2024 Aug 31;404(10455):e3.

doi: 10.1016/S0140-6736(19)32643-1. Epub 2019 Oct 31.

No abstract available

Erratum for

Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial.
Ferrari MD, Diener HC, Ning X, Galic M, Cohen JM, Yang R, Mueller M, Ahn AH, Schwartz YC, Grozinski-Wolff M, Janka L, Ashina M. Ferrari MD, et al. Lancet. 2019 Sep 21;394(10203):1030-1040. doi: 10.1016/S0140-6736(19)31946-4. Epub 2019 Aug 16. Lancet. 2019. PMID: 31427046 Clinical Trial.